FibroBiologics, Inc. Common Stock (FBLG) vs GeoVax Labs, Inc. (GOVX)
A side-by-side comparison of FibroBiologics, Inc. Common Stock and GeoVax Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBLG
FibroBiologics, Inc. Common Stock
$1.20HealthcareDelayed quote: Oct 6, 2026, 12:04 PM EDT
GOVX
GeoVax Labs, Inc.
$0.31HealthcareDelayed quote: Oct 6, 2026, 12:06 PM EDT
Not enough overlapping price history to compare FBLG and GOVX.
FBLG vs GOVX: by the numbers
- •FBLG is the larger company ($3M vs $2M market cap).
- •Both run net losses; FBLG's is the smaller (0.00% vs -862.34% net margin).
Metrics side by side
Valuation
| Metric | FBLG | GOVX |
|---|---|---|
| P/B ratio | 0.54 | 1.28 |
Profitability
| Metric | FBLG | GOVX |
|---|---|---|
| Gross margin | 0.00% | -628.02% |
| Operating margin | 0.00% | -869.34% |
| Net margin | 0.00% | -862.34% |
| ROE | -391.26% | -1160.10% |
| ROIC | -286.46% | -985.20% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.